Efficacy and Tolerability of Botulinum Toxin Type A in Patients with Neurogenic Detrusor Overactivity and Without Concomitant Anticholinergic Therapy: Comparison of Two Doses

Chapple, 2008, The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis, Eur Urol, 54, 543, 10.1016/j.eururo.2008.06.047 Giannantoni, 2004, Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study, J Urol, 172, 240, 10.1097/01.ju.0000132152.53532.5d Schurch, 2005, Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study, J Urol, 174, 196, 10.1097/01.ju.0000162035.73977.1c Ehren, 2007, Efficacy and impact of botulinum toxin A on quality of life in patients with neurogenic detrusor overactivity: a randomised, placebo-controlled, double-blind study, Scand J Urol Nephrol, 41, 335, 10.1080/00365590601068835 Del Popolo, 2008, Neurogenic detrusor overactivity treated with English botulinum toxin A: 8-year experience of one single centre, Eur Urol, 53, 1013, 10.1016/j.eururo.2007.09.034 Ruffion, 2006, What is the optimum dose of type A botulinum toxin for treating neurogenic bladder overactivity?, BJU Int, 97, 1030, 10.1111/j.1464-410X.2006.06091.x Hori, 2009, Patients’ perspective of botulinum toxin-A as a long-term treatment option for neurogenic detrusor overactivity secondary to spinal cord injury, BJU Int, 104, 216, 10.1111/j.1464-410X.2009.08368.x Stoehrer, 2009, Treatment of neurogenic detrusor overactivity with botulinum toxin A: the first seven years, Urol Int, 83, 379, 10.1159/000251175 Ghalayini, 2009, Is efficacy of repeated intradetrusor botulinum toxin type A (Dysport) injections dose dependent? Clinical and urodynamic results after four injections in patients with drug-resistant neurogenic detrusor overactivity, Int Urol Nephrol, 41, 805, 10.1007/s11255-009-9528-y Patel, 2006, Botulinum toxin injections for neurogenic and idiopathic detrusor overactivity: a critical analysis of results, Eur Urol, 50, 684, 10.1016/j.eururo.2006.07.022 Karsenty, 2008, Botulinum toxin A (Botox®) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review, Eur Urol, 53, 275, 10.1016/j.eururo.2007.10.013 Apostolidis, 2009, Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report, Eur Urol, 55, 100, 10.1016/j.eururo.2008.09.009 De Laet, 2005, Adverse events after botulinum A toxin injection for neurogenic voiding disorders, Spinal Cord, 43, 397, 10.1038/sj.sc.3101736 Klaphajone, 2005, Botulinum toxin type A injections for treating neurogenic detrusor overactivity combined with low-compliance bladder in patients with spinal cord lesions, Arch Phys Med Rehabil, 86, 2114, 10.1016/j.apmr.2005.06.008 Schulte-Baukloh, 2006, Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis, Neurourol Urodyn, 25, 110, 10.1002/nau.20153 Kuo, 2006, Therapeutic effects of suburothelial injection of botulinum a toxin for neurogenic detrusor overactivity due to chronic cerebrovascular accident and spinal cord lesions, Urology, 67, 232, 10.1016/j.urology.2005.08.016 Costa, 2001, Quality of life in spinal cord injury patients with urinary difficulties: development and validation of Qualiveen, Eur Urol, 39, 107, 10.1159/000052421 Grosse, 2005, Success of repeat detrusor injections of botulinum A toxin in patients with severe neurogenic detrusor overactivity and incontinence, Eur Urol, 47, 653, 10.1016/j.eururo.2004.11.009 Karsenty, 2006, Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity, Urology, 68, 1193, 10.1016/j.urology.2006.08.1069 Giannantoni, 2009, Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results, Eur Urol, 55, 705, 10.1016/j.eururo.2008.08.048 Reitz, 2007, Do repeat intradetrusor botulinum toxin type A injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity, Eur Urol, 52, 1729, 10.1016/j.eururo.2007.08.052